HomeMedication lookupGenes › SLCO1B1
SLCO1B1

Drugs affected by SLCO1B1

Solute Carrier Organic Anion Transporter 1B1

7 medications 8 brand products

About SLCO1B1

SLCO1B1 is the transporter that moves statins into liver cells where they work. A common variant (called *5) reduces transporter function and leaves more statin circulating in the bloodstream and muscle tissue.[1] That's directly linked to statin-associated muscle pain and, rarely, more serious muscle damage.[2]

People with reduced SLCO1B1 function are at higher risk of statin myopathy, especially on simvastatin and high-dose atorvastatin. Dose reduction or switching statin usually resolves it.[3]

What we test for SLCO1B1

Gene2Rx reports your SLCO1B1 genotype across 36 named star alleles, built from 29 variants curated by PharmVar.

36
Star alleles
29
Variants tested
PharmVar
Source
GRCh38
Genome build
Normal Function 2 Increased Function 3 Decreased Function 8 Possible Decreased Function 4 Unknown or Uncertain Function 19

Notable SLCO1B1 alleles

*1A Normal Function
Reference allele — normal SLCO1B1 transporter activity.
*5 Decreased Function
A decreased-function allele defined by rs4149056 (c.521T>C); raises statin exposure and myopathy risk.
~15% in Europeans
*15 Decreased Function
A decreased-function haplotype carrying the *5 variant; same statin-myopathy implications.
What are star alleles?

Star alleles (like *1, *2, *4) are standardized names for distinct versions of a pharmacogene. *1 is the reference; higher numbers identify variants discovered later that change the enzyme's activity.

You inherit one allele from each parent, so your genotype is a pair (e.g. *1/*4). The pair determines your predicted phenotype — for example, whether you metabolize a drug at a normal, decreased, or no-function rate.

PharmVar is the international registry that defines and curates these allele names. Gene2Rx tests the variants required to call every SLCO1B1 allele in the PharmVar catalog.

Medications with SLCO1B1 guidelines

Gene2Rx covers 7 medications with published pharmacogenetic guidance for SLCO1B1, drawn from CPIC and FDA sources. Each drug links to its full pharmacogenetics page.

Brand products containing a SLCO1B1-affected ingredient

These branded medications include at least one active ingredient whose metabolism or action involves SLCO1B1. Each links to its full pharmacogenetic breakdown.

References

  1. CPIC. CPIC Guideline for Statins and SLCO1B1, ABCG2, and CYP2C9 (2022). cpicpgx.org
  2. U.S. Food and Drug Administration. Table of Pharmacogenomic Biomarkers in Drug Labeling (2024). fda.gov
  3. PharmGKB / Stanford University. PharmGKB: The Pharmacogenomics Knowledge Base. pharmgkb.org

Find out your personal SLCO1B1 phenotype

This page lists drugs affected by SLCO1B1. A Gene2Rx report tells you which metabolizer group you fall into, and what that means for every medication on this list.

Get your report Look up a medication

Informational only, not medical advice. The presence of a SLCO1B1 pharmacogenetic guideline does not mean every patient needs to change their dose. Never start, stop, or change a medication without talking to your prescribing clinician.

Get Your Report Now
Ready in One Minute